GSK said today that a large phase 3 trial of a once highly-promising drug had failed to meet its primary endpoint. Last year the company announced that another phase 3 trial with the same drug had failed. GSK said it would “further analyse the data and better understand the findings” but […] > READ MORE
About Health News
Health Host's RSS feed: Automatically delivering the latest news, reviews, and headlines in health.
This site uses Akismet to reduce spam. Learn how your comment data is processed.